Dergiler / Addicta: The Turkish Journal on Addictions / 2022 / Cilt: 9 - Sayı: 2

Impact of Smoking on Disease Severity and Mortality of Hospitalized Patients with Confirmed COVID-19

Sayfa
121–125
Yayın Tarihi
2022-11-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, smokers should quit smoking urgently to be affected by the pandemic at a minimum level.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:COVID-19 is a newly defined pandemic agent.
📊
Temel Bulgular & Veri:Exposure to cigarette smoke causes increased mucosal inflammation, expression of inflammatory cytokines, impaired mucociliary clearance, and excessive mucus production.
💡
Sonuç & Katkı:Therefore, smokers should quit smoking urgently to be affected by the pandemic at a minimum level.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

COVID-19 is a newly defined pandemic agent. Exposure to cigarette smoke causes increased mucosal inflammation, expression of inflammatory cytokines, impaired mucociliary clearance, and excessive mucus production. Changes in the lungs due to smoking can directly affect the outcome of the disease. In this study, we evaluated the relationship between smoking and the clinical severity of COVID-19. The charts of the patients with positive real-time polymerase chain reaction (RT-PCR) tests who received inpatient treatment in COVID-19 clinics between November 2020-April 2021 were reviewed retrospectively. Patients were divided into two groups smokers and non-smokers. We compared two groups’ age, gender, labora- tory parameters, mortality status, and disease severity. We included PCR proven 165 smokers and 351 non-smokers who needed hospitalization. The number of female patients was significantly lower in the smoker group (F/M: 33/132)(p < 0.001). The clinically severe patient rate was higher in the smoker group (p = 0.005). Although the rate of mortality and patients who need ventilatory support were higher in the smoker group, the differences could not reach statistical significance. This study showed smokers had a more severe COVID-19 course than non-smokers, but the clinical outcome of severe/critical patients was not affected by the smoking status. Therefore, smokers should quit smoking urgently to be affected by the pandemic at a minimum level.

🔖

Bu Makaleye Atıf Yap

Güllü, Y. T., Kulucan, E., Tuna, N. T., Köksal, N., Koca, N. (2022). Impact of Smoking on Disease Severity and Mortality of Hospitalized Patients with Confirmed COVID-19. Addicta: The Turkish Journal on Addictions, Cilt: 9 - Sayı: 2, 121–125. https://ajindex.com/articles/856971

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Arcavi, L., & Benowitz, N. L. (2004). Cigarette smoking and infection [Review]. Archives of Internal Medicine, 164(20), 2206–2216. [CrossRef] Caliskan, T., & Saylan, B. (2020). Smoking and comorbidities are associ- ated with COVID-19 severity and mortality in 565 patients treated in Turkey: A retrospective observational study. Revista da Asso - ciação Médica Brasileira, 66(12), 1679–1684. [CrossRef] Çetin Kargin, N. (2021). The effect of smoking on COVID-19-linked bio- markers in hospitalized patients with COVID-19.Journal of Clinical Laboratory Analysis, 35(10), e23983. [CrossRef] Chen, L., Zhang, B., Ti, M. N., Yang, K., Zou, Y., & Zhang, S. (2020). Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study. Journal of Infec - tion, 81(2), e82–e84. [CrossRef] Dye, J. A., & Adler, K. B. (1994). Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax, 49(8), 825–834. [CrossRef] Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S. C., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. [CrossRef] Heydari, G., & Arfaeinia, H. (2021). COVID-19 and smoking: More sever- ity and death - An experience from Iran. Lung India, 38(Suppl.), S27–S30. [CrossRef] Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497–506. [CrossRef] Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020). C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis. Therapeutic Advances in Respiratory Disease, 14, 1753466620937175. [CrossRef] Lippi, G., & Henry, B. M. (2020). Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). European Journal of Internal Medicine, 75, 107–108. [CrossRef] Patanavanich, R., & Glantz, S. A. (2020). Smoking is associated with COVID-19 progression: A meta-analysis. Nicotine and Tobacco Research, 22(9), 1653–1656. [CrossRef] Sopori, M. L., Kozak, W., Savage, S. M., Geng, Y., Soszynski, D